schliessen

Filtern

 

Bibliotheken

Barriers and motivations for participation in preventive vaccine clinical trials: Experience of 5 clinical research sites

Recruitment in preventive vaccine trials (PVT) is challenging due to common barriers to clinical research and lack of vaccine confidence. Identifying determinants of participation can help to improve recruitment. A prospective survey was conducted in 5 French clinical investigational sites. People a... Full description

Journal Title: Vaccine 2019, Vol.37 (44), p.6633-6639
Main Author: Detoc, M
Other Authors: Launay, O , Dualé, C , Mutter, C , Le Huec, J.-C , Lenzi, N , Lucht, F , Gagneux-Brunon, A , Botelho-Nevers, E
Format: Electronic Article Electronic Article
Language: English
Subjects:
Quelle: Alma/SFX Local Collection
Publisher: Kidlington: Elsevier Ltd
ID: ISSN: 0264-410X
Link: https://hal.archives-ouvertes.fr/hal-02460331
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_hal_primary_oai_HAL_hal_02460331v1
title: Barriers and motivations for participation in preventive vaccine clinical trials: Experience of 5 clinical research sites
format: Article
creator:
  • Detoc, M
  • Launay, O
  • Dualé, C
  • Mutter, C
  • Le Huec, J.-C
  • Lenzi, N
  • Lucht, F
  • Gagneux-Brunon, A
  • Botelho-Nevers, E
subjects:
  • Acceptance tests
  • Altruism
  • Barriers
  • Clinical decision making
  • Clinical trials
  • Cognition
  • Decision making
  • Disease
  • Disease prevention
  • Family physicians
  • Health care
  • Immunization
  • Incentives
  • Influenza
  • Life Sciences
  • Medication
  • Motivation
  • Motivations
  • Multivariate analysis
  • Neurons
  • Neurons and Cognition
  • Participation
  • Pharmaceutical sciences
  • Pharmacology
  • Polls & surveys
  • Questionnaires
  • Recruitment
  • Side effects
  • Software
  • Studies
  • Vaccine
  • Vaccine clinical trial
  • Vaccines
ispartof: Vaccine, 2019, Vol.37 (44), p.6633-6639
description: Recruitment in preventive vaccine trials (PVT) is challenging due to common barriers to clinical research and lack of vaccine confidence. Identifying determinants of participation can help to improve recruitment. A prospective survey was conducted in 5 French clinical investigational sites. People asked to participate in a PVT were given a questionnaire whether they decided to participate or not in the trial. A total of 341 people answered the survey: 210 accepting and 131 declining to participate in a PVT. Acceptors were significantly younger (38.5 vs 54.9 years old), more likely to be involved in early phase trials, had a higher level of education (p 
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 0264-410X
fulltext: fulltext
issn:
  • 0264-410X
  • 1873-2518
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.588913
LOCALfalse
PrimoNMBib
record
control
sourceidproquest_opena
recordidTN_cdi_hal_primary_oai_HAL_hal_02460331v1
sourceformatXML
sourcesystemPC
sourcerecordid2299730033
originalsourceidFETCH-LOGICAL-c480t-943ad836ee59f7439dc131dc61424df57ebcf63ab417933f37594ec24eed06d83
addsrcrecordideNqNklGL1DAQgIsouK7-BCHgiz50zTRp2vgi53G6wqIvCr6FXDLhsnSTmnRX79-bXhdFX04YSAjffElmpqqeA90ABfF6vzlpY3zATUNBbmgJ3j-oVtB3rG5a6B9WK9oIXnOg3x5XT3LeU0pbBnJV3b7TKXlMmehgySFO_qQnH0MmLiYy6jR548e7I-IDGROeMBQIyflOYgYfvNEDmZLXQ35Drn6OWJTBIImOtH-AhBl1Mjck-wnz0-qRKzw-O6_r6uv7qy-X23r3-cPHy4tdbXhPp1pypm3PBGIrXceZtAYYWCOAN9y6tsNr4wTT1xw6yZhjXSs5moYjWipK5rraLt44YtA-oRqTP-h0q6L2ygacVLQKRKsEtWBAo7MCQDuGSG3PJeuE7GRXNuvq030qi_Y4qh9OUQr_I3y1CG_08Jdre7FT8xltuKCMwQkK-3JhxxS_HzFP6uCzwWHQAeMxq6aR5ZauF_OXX_yD7uMxhVLlmZIdo8VZqHahTIo5J3S_XwBUzYOl9urcZDUPlqIl-Gx_u-Rh6dqpzI7K5q7dtlTElBJEf4_hF4Wb19U
sourcetypeOpen Access Repository
isCDItrue
recordtypearticle
pqid2299730033
display
typearticle
titleBarriers and motivations for participation in preventive vaccine clinical trials: Experience of 5 clinical research sites
sourceAlma/SFX Local Collection
creatorDetoc, M ; Launay, O ; Dualé, C ; Mutter, C ; Le Huec, J.-C ; Lenzi, N ; Lucht, F ; Gagneux-Brunon, A ; Botelho-Nevers, E
creatorcontribDetoc, M ; Launay, O ; Dualé, C ; Mutter, C ; Le Huec, J.-C ; Lenzi, N ; Lucht, F ; Gagneux-Brunon, A ; Botelho-Nevers, E
descriptionRecruitment in preventive vaccine trials (PVT) is challenging due to common barriers to clinical research and lack of vaccine confidence. Identifying determinants of participation can help to improve recruitment. A prospective survey was conducted in 5 French clinical investigational sites. People asked to participate in a PVT were given a questionnaire whether they decided to participate or not in the trial. A total of 341 people answered the survey: 210 accepting and 131 declining to participate in a PVT. Acceptors were significantly younger (38.5 vs 54.9 years old), more likely to be involved in early phase trials, had a higher level of education (p < 0.005) and a significantly better general opinion concerning vaccines (92.3% versus 72.3%, p < 0.005) compared with those who declined. Factors associated with acceptance or refusal were evaluated in 224 people in the 4 sites where both groups were included. In a multivariate analysis, three factors: older age, having heard about PVT through multiple sources and financial incentives were significantly associated with refusal to participate in the PVT. A generally favourable opinion of vaccines was associated with acceptance. The main motivation for participation was altruism (93.2%) whereas fear of side effects was at the forefront of the barriers (36.6%). Information given by the physician was a key point for decision-making in 70.2% of those who accepted. In brief, vaccine hesitancy may decrease recruitment in PVTs; reinforcing altruism and quality of information given are key points in acceptance of participation in PVT.
identifier
0ISSN: 0264-410X
1EISSN: 1873-2518
2DOI: 10.1016/j.vaccine.2019.09.048
languageeng
publisherKidlington: Elsevier Ltd
subjectAcceptance tests ; Altruism ; Barriers ; Clinical decision making ; Clinical trials ; Cognition ; Decision making ; Disease ; Disease prevention ; Family physicians ; Health care ; Immunization ; Incentives ; Influenza ; Life Sciences ; Medication ; Motivation ; Motivations ; Multivariate analysis ; Neurons ; Neurons and Cognition ; Participation ; Pharmaceutical sciences ; Pharmacology ; Polls & surveys ; Questionnaires ; Recruitment ; Side effects ; Software ; Studies ; Vaccine ; Vaccine clinical trial ; Vaccines
ispartofVaccine, 2019, Vol.37 (44), p.6633-6639
rights
02019
1Copyright Elsevier Limited Oct 16, 2019
2Attribution - NonCommercial
lds50peer_reviewed
oafree_for_read
orcidid0000-0003-2773-7750 ; 0000-0002-0892-2187
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://hal.archives-ouvertes.fr/hal-02460331$$DView record in HAL
search
creatorcontrib
0Detoc, M
1Launay, O
2Dualé, C
3Mutter, C
4Le Huec, J.-C
5Lenzi, N
6Lucht, F
7Gagneux-Brunon, A
8Botelho-Nevers, E
title
0Barriers and motivations for participation in preventive vaccine clinical trials: Experience of 5 clinical research sites
1Vaccine
descriptionRecruitment in preventive vaccine trials (PVT) is challenging due to common barriers to clinical research and lack of vaccine confidence. Identifying determinants of participation can help to improve recruitment. A prospective survey was conducted in 5 French clinical investigational sites. People asked to participate in a PVT were given a questionnaire whether they decided to participate or not in the trial. A total of 341 people answered the survey: 210 accepting and 131 declining to participate in a PVT. Acceptors were significantly younger (38.5 vs 54.9 years old), more likely to be involved in early phase trials, had a higher level of education (p < 0.005) and a significantly better general opinion concerning vaccines (92.3% versus 72.3%, p < 0.005) compared with those who declined. Factors associated with acceptance or refusal were evaluated in 224 people in the 4 sites where both groups were included. In a multivariate analysis, three factors: older age, having heard about PVT through multiple sources and financial incentives were significantly associated with refusal to participate in the PVT. A generally favourable opinion of vaccines was associated with acceptance. The main motivation for participation was altruism (93.2%) whereas fear of side effects was at the forefront of the barriers (36.6%). Information given by the physician was a key point for decision-making in 70.2% of those who accepted. In brief, vaccine hesitancy may decrease recruitment in PVTs; reinforcing altruism and quality of information given are key points in acceptance of participation in PVT.
subject
0Acceptance tests
1Altruism
2Barriers
3Clinical decision making
4Clinical trials
5Cognition
6Decision making
7Disease
8Disease prevention
9Family physicians
10Health care
11Immunization
12Incentives
13Influenza
14Life Sciences
15Medication
16Motivation
17Motivations
18Multivariate analysis
19Neurons
20Neurons and Cognition
21Participation
22Pharmaceutical sciences
23Pharmacology
24Polls & surveys
25Questionnaires
26Recruitment
27Side effects
28Software
29Studies
30Vaccine
31Vaccine clinical trial
32Vaccines
issn
00264-410X
11873-2518
fulltexttrue
rsrctypearticle
creationdate2019
recordtypearticle
recordideNqNklGL1DAQgIsouK7-BCHgiz50zTRp2vgi53G6wqIvCr6FXDLhsnSTmnRX79-bXhdFX04YSAjffElmpqqeA90ABfF6vzlpY3zATUNBbmgJ3j-oVtB3rG5a6B9WK9oIXnOg3x5XT3LeU0pbBnJV3b7TKXlMmehgySFO_qQnH0MmLiYy6jR548e7I-IDGROeMBQIyflOYgYfvNEDmZLXQ35Drn6OWJTBIImOtH-AhBl1Mjck-wnz0-qRKzw-O6_r6uv7qy-X23r3-cPHy4tdbXhPp1pypm3PBGIrXceZtAYYWCOAN9y6tsNr4wTT1xw6yZhjXSs5moYjWipK5rraLt44YtA-oRqTP-h0q6L2ygacVLQKRKsEtWBAo7MCQDuGSG3PJeuE7GRXNuvq030qi_Y4qh9OUQr_I3y1CG_08Jdre7FT8xltuKCMwQkK-3JhxxS_HzFP6uCzwWHQAeMxq6aR5ZauF_OXX_yD7uMxhVLlmZIdo8VZqHahTIo5J3S_XwBUzYOl9urcZDUPlqIl-Gx_u-Rh6dqpzI7K5q7dtlTElBJEf4_hF4Wb19U
startdate20191016
enddate20191016
creator
0Detoc, M
1Launay, O
2Dualé, C
3Mutter, C
4Le Huec, J.-C
5Lenzi, N
6Lucht, F
7Gagneux-Brunon, A
8Botelho-Nevers, E
general
0Elsevier Ltd
1Elsevier Limited
2Elsevier
scope
0AAYXX
1CITATION
23V.
37QL
47RV
57T2
67T5
77U9
87X7
97XB
1088C
1188E
128AO
138C1
148FE
158FH
168FI
178FJ
188FK
198G5
20ABUWG
21AZQEC
22BBNVY
23BENPR
24BHPHI
25C1K
26DWQXO
27FYUFA
28GHDGH
29GNUQQ
30GUQSH
31H94
32HCIFZ
33K9-
34K9.
35KB0
36LK8
37M0R
38M0S
39M0T
40M1P
41M2O
42M7N
43M7P
44MBDVC
45NAPCQ
46PQEST
47PQQKQ
48PQUKI
49Q9U
507X8
511XC
52VOOES
53BOBZL
54CLFQK
orcidid
0https://orcid.org/0000-0003-2773-7750
1https://orcid.org/0000-0002-0892-2187
sort
creationdate20191016
titleBarriers and motivations for participation in preventive vaccine clinical trials: Experience of 5 clinical research sites
authorDetoc, M ; Launay, O ; Dualé, C ; Mutter, C ; Le Huec, J.-C ; Lenzi, N ; Lucht, F ; Gagneux-Brunon, A ; Botelho-Nevers, E
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-c480t-943ad836ee59f7439dc131dc61424df57ebcf63ab417933f37594ec24eed06d83
rsrctypearticles
prefilterarticles
languageeng
creationdate2019
topic
0Acceptance tests
1Altruism
2Barriers
3Clinical decision making
4Clinical trials
5Cognition
6Decision making
7Disease
8Disease prevention
9Family physicians
10Health care
11Immunization
12Incentives
13Influenza
14Life Sciences
15Medication
16Motivation
17Motivations
18Multivariate analysis
19Neurons
20Neurons and Cognition
21Participation
22Pharmaceutical sciences
23Pharmacology
24Polls & surveys
25Questionnaires
26Recruitment
27Side effects
28Software
29Studies
30Vaccine
31Vaccine clinical trial
32Vaccines
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Detoc, M
1Launay, O
2Dualé, C
3Mutter, C
4Le Huec, J.-C
5Lenzi, N
6Lucht, F
7Gagneux-Brunon, A
8Botelho-Nevers, E
collection
0CrossRef
1ProQuest Central (Corporate)
2Bacteriology Abstracts (Microbiology B)
3Nursing & Allied Health Database
4Health and Safety Science Abstracts (Full archive)
5Immunology Abstracts
6Virology and AIDS Abstracts
7Health & Medical Collection
8ProQuest Central (purchase pre-March 2016)
9Healthcare Administration Database (Alumni)
10Medical Database (Alumni Edition)
11ProQuest Pharma Collection
12Public Health Database
13ProQuest SciTech Collection
14ProQuest Natural Science Collection
15Hospital Premium Collection
16Hospital Premium Collection (Alumni Edition)
17ProQuest Central (Alumni) (purchase pre-March 2016)
18Research Library (Alumni Edition)
19ProQuest Central (Alumni Edition)
20ProQuest Central Essentials
21Biological Science Collection
22ProQuest Central
23Natural Science Collection
24Environmental Sciences and Pollution Management
25ProQuest Central Korea
26Health Research Premium Collection
27Health Research Premium Collection (Alumni)
28ProQuest Central Student
29Research Library Prep
30AIDS and Cancer Research Abstracts
31SciTech Premium Collection
32Consumer Health Database (Alumni Edition)
33ProQuest Health & Medical Complete (Alumni)
34Nursing & Allied Health Database (Alumni Edition)
35ProQuest Biological Science Collection
36Consumer Health Database
37Health & Medical Collection (Alumni Edition)
38Healthcare Administration Database
39Medical Database
40Research Library
41Algology Mycology and Protozoology Abstracts (Microbiology C)
42Biological Science Database
43Research Library (Corporate)
44Nursing & Allied Health Premium
45ProQuest One Academic Eastern Edition
46ProQuest One Academic
47ProQuest One Academic UKI Edition
48ProQuest Central Basic
49MEDLINE - Academic
50Hyper Article en Ligne (HAL)
51Hyper Article en Ligne (HAL) (Open Access)
52OpenAIRE (Open Access)
53OpenAIRE
jtitleVaccine
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Detoc, M
1Launay, O
2Dualé, C
3Mutter, C
4Le Huec, J.-C
5Lenzi, N
6Lucht, F
7Gagneux-Brunon, A
8Botelho-Nevers, E
formatjournal
genrearticle
ristypeJOUR
atitleBarriers and motivations for participation in preventive vaccine clinical trials: Experience of 5 clinical research sites
jtitleVaccine
date2019-10-16
risdate2019
volume37
issue44
spage6633
epage6639
pages6633-6639
issn0264-410X
eissn1873-2518
abstractRecruitment in preventive vaccine trials (PVT) is challenging due to common barriers to clinical research and lack of vaccine confidence. Identifying determinants of participation can help to improve recruitment. A prospective survey was conducted in 5 French clinical investigational sites. People asked to participate in a PVT were given a questionnaire whether they decided to participate or not in the trial. A total of 341 people answered the survey: 210 accepting and 131 declining to participate in a PVT. Acceptors were significantly younger (38.5 vs 54.9 years old), more likely to be involved in early phase trials, had a higher level of education (p < 0.005) and a significantly better general opinion concerning vaccines (92.3% versus 72.3%, p < 0.005) compared with those who declined. Factors associated with acceptance or refusal were evaluated in 224 people in the 4 sites where both groups were included. In a multivariate analysis, three factors: older age, having heard about PVT through multiple sources and financial incentives were significantly associated with refusal to participate in the PVT. A generally favourable opinion of vaccines was associated with acceptance. The main motivation for participation was altruism (93.2%) whereas fear of side effects was at the forefront of the barriers (36.6%). Information given by the physician was a key point for decision-making in 70.2% of those who accepted. In brief, vaccine hesitancy may decrease recruitment in PVTs; reinforcing altruism and quality of information given are key points in acceptance of participation in PVT.
copKidlington
pubElsevier Ltd
doi10.1016/j.vaccine.2019.09.048
orcidid
0https://orcid.org/0000-0003-2773-7750
1https://orcid.org/0000-0002-0892-2187
oafree_for_read